Tag: stages

HYDERABAD, INDIA & REYKJAVIK, ICELAND (June 5, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide (“Alvotech”), and Dr. Reddy’s Laboratories Ltd., (BSE: 500124 | NSE: DRREDDY | NYSE: RDY | NSEIFSC: DRREDDY, along with its subsidiaries hereafter referred to as “Dr. Reddy’s”), today announced that the companies have entered into a collaboration and license agreement to co-develop, manufacture and commercialize a biosimilar candidate to Keytruda® (pembrolizumab) for global markets. Keytruda® (pembrolizumab) is indicated for the treatment of numerous cancer types. In 2024, worldwide sales of Keytruda were US$29.5 billion [1]. The collaboration combines Dr. Reddy’s and Alvotech’s proven capabilities in biosimilars, thereby, speeding up the development process and extending the global reach for this biosimilar candidate.

NEW YORK, June 04, 2025 (GLOBE NEWSWIRE) -- Insurtech Insights USA 2025, North America’s premier gathering of insurance executives and innovators, kicked off today at the Javits Center with record energy from 6,000+ attendees, fresh perspectives, and a bold vision for the future of insurance. With thousands of executives, investors, and founders in attendance, the first day of the conference delivered powerful discussions across multiple stages, spotlighting how AI, innovation, and leadership are actively reshaping the insurance landscape.